TABLE 2.
Characterization of eight independent mutants resistant to neutralization by p75-Fca
Name of mutant | Plaque phenotype | Mutation in glycoprotein gene
|
||
---|---|---|---|---|
Amino acid no. | Nature of substitution | Change in codon | ||
2-4 | small | 352 | H to R | CAT to CGT |
4-1 | small | 352 | H to R | CAT to CGT |
5-4∗ | large | 318 | F to V | TTC to GTC |
6-5∗ | small | 318 | F to S | TTC to TCC |
7-5∗ | large | 352 | H to Y | CAT to TAT |
8-2 | large | 318 | F to V | TTC to GTC |
9-1∗ | small | 352 | H to R | CAT to CGT |
10-5 | small | 318 | F to S | TTC to TCC |
One mutant per CVS stock was amplified and analyzed for the plaque phenotype on BSR cells. The entire gene of the glycoprotein was sequenced for the mutants noted by an asterisk, and partial sequence (amino acids 254 to 429) was obtained for the others.